A Phase Il Clinical Study to Evaluate the Efficacy and Safety of HG146 Capsules in Participants with Recurrent or Metastatic Adenoid Cystic Carcinoma.
Latest Information Update: 23 Jan 2025
Price :
$35 *
At a glance
- Drugs HG-146 (Primary)
- Indications Adenocarcinoma
- Focus Therapeutic Use
- Sponsors HitGen
- 23 Jan 2025 New trial record